Nimish P Shah's Net Worth

$0

Estimate Recalculated Nov 11, 2024 01:52PM EST

Who is Nimish P Shah

Nimish P Shah does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include KalVista Pharmaceuticals, Inc., Instil Bio, Inc., CONSTELLATION PHARMACEUTICALS INC, Apogee Therapeutics, Inc., Shockwave Medical, Inc., Altimmune, Inc., Unum Therapeutics Inc., Bellerophon Therapeutics, Inc., Tricida, Inc., Vistagen Therapeutics, Inc., and ARCA biopharma, Inc..

SEC CIK

Nimish P Shah's CIK is 0001698082

Past Insider Trading and Trends

2021 was Nimish P Shah's most active year for acquiring shares with 1 total transactions. Nimish P Shah's most active month to acquire stocks was the month of February. 2021 saw Nimish P Shah paying a total of $0.00 for 52,000 shares, this is the most they've acquired in one year.

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

KalVista Pharmaceuticals, Inc.

Investor
Updated Feb 22, 2024
Form 4
655.74K
$15.25
$10.00M
Feb 22, 2024
655.74K
Purchase
Feb 20
Form 4
1.82%
86.05K
$14.62
$1.26M
Feb 08, 2024
4.82M
Purchase
Feb 06 - Feb 08
Form 4
1.89%
88.10K
$14.47
$1.27M
Feb 01, 2024
4.74M
Purchase
Jan 30
Form 4
2.01%
91.80K
$14.05
$1.29M
Jan 29, 2024
4.65M
Purchase
Jan 25 - Jan 29
Form 4
2.22%
99.13K
$12.53
$1.24M
Jan 24, 2024
4.56M
Purchase
Jan 22 - Jan 24
Form 4
3.33%
143.60K
$12.55
$1.80M
Jan 19, 2024
4.46M
Purchase
Jan 17 - Jan 19
Form 4
0.61%
26.25K
$12.72
$333.78K
Jan 16, 2024
4.32M
Purchase
Jan 11 - Jan 16
Form 4
3.32%
137.70K
$12.54
$1.73M
Jan 10, 2024
4.29M
Purchase
Jan 08 - Jan 10
Form 4
1.45%
59.37K
$12.14
$720.54K
Jan 05, 2024
4.15M
Purchase
Jan 03 - Jan 04
Form 4
14.52%
519.02K
$12.46
$6.47M
Dec 29, 2023
4.09M
Purchase
Dec 27 - Dec 29
Form 3
Dec 28, 2023
3.57M
Form 4
-24.46%
-500.00K
$28.75
-$14.37M
Mar 20, 2019
1.54M
Sale
Mar 18
Form 3
Sep 10, 2018
2.04M
Showing 13 results

Instil Bio, Inc.

Investor
Updated Mar 25, 2021
Form 4
7.90%
1.39M
$20.00
$6.00M
Mar 25, 2021
19.04M
Purchase
Mar 23
Form 4
52.00K
Mar 22, 2021
52.00K
Grant
Mar 18
Form 3/A
Mar 22, 2021
Form 3
Mar 18, 2021
Showing 4 results

CONSTELLATION PHARMACEUTICALS INC

Investor
Updated Dec 16, 2019
Form 4
11.06%
400.00K
$34.50
$13.80M
Dec 16, 2019
4.02M
Purchase
Dec 13
Form 3
Oct 04, 2019
3.62M
Showing 2 results

Apogee Therapeutics, Inc.

Investor
Updated Jun 07, 2024
Form 4
10.37K
Jun 07, 2024
10.37K
Grant
Jun 05
Form 4
1.80M
$17.00
$29.75M
Jul 17, 2023
1.80M
Purchase
Jul 13
Form 3
Jul 13, 2023
Showing 3 results

Shockwave Medical, Inc.

Investor
Updated Mar 13, 2019
Form 4
4.24M
Mar 13, 2019
2.12M
Options
Mar 11
Form 3
Mar 06, 2019
Showing 2 results

Altimmune, Inc.

Investor
Updated Mar 01, 2021
Form 4
Mar 01, 2021
4.50M
Acq/Dis
Feb 25
Form 4
50.00%
1.50M
$7.54
$11.31M
Jun 15, 2020
4.50M
Purchase
Jun 15
Form 4
76.85%
1.30M
$8.74
$11.40M
May 28, 2020
3.00M
Purchase
May 26 - May 28
Form 3
May 28, 2020
1.70M
Showing 4 results

Unum Therapeutics Inc.

Investor
Updated Aug 18, 2020
Form 4
11.55%
451.00K
$2.52
$1.14M
Aug 18, 2020
4.36M
Purchase
Aug 14 - Aug 18
Form 3
Aug 18, 2020
3.90M
Showing 2 results

Bellerophon Therapeutics, Inc.

Investor
Updated Oct 28, 2019
Form 4
-14.53%
-1.09M
$0.48
-$524.96K
Oct 28, 2019
6.44M
Sale
Oct 24 - Oct 28
Form 4
1.93%
142.86K
$0.70
$100.00K
Mar 14, 2019
7.53M
Purchase
Jan 23
Form 4
2.93%
210.00K
$1.20
$252.35K
Sep 17, 2018
7.39M
Purchase
Sep 13 - Sep 17
Form 4
7.09%
475.00K
$1.18
$558.39K
Sep 12, 2018
7.18M
Purchase
Sep 10 - Sep 12
Form 4
2.45%
160.00K
$0.86
$138.16K
Sep 07, 2018
6.70M
Purchase
Sep 05 - Sep 07
Form 4
8.81%
529.37K
$0.65
$342.88K
Aug 16, 2018
6.54M
Purchase
Aug 14 - Aug 16
Form 3
Aug 16, 2018
6.01M
Showing 7 results

Tricida, Inc.

Investor
Updated Oct 26, 2022
Form 4
-63.23%
-6.45M
$0.54
-$3.50M
Oct 26, 2022
3.75M
Sale
Oct 24 - Oct 26
Form 4
3.57%
351.87K
$10.68
$3.76M
Oct 20, 2022
10.20M
Purchase
Oct 18 - Oct 19
Form 4
1.81%
174.97K
$11.68
$2.04M
Oct 17, 2022
9.85M
Purchase
Oct 13 - Oct 17
Form 4
1.41%
134.21K
$11.91
$1.60M
Oct 11, 2022
9.68M
Purchase
Oct 07 - Oct 11
Form 4
2.39%
223.10K
$11.81
$2.63M
Oct 06, 2022
9.54M
Purchase
Oct 04
Form 4
4.92%
436.92K
$10.75
$4.70M
Oct 03, 2022
9.32M
Purchase
Sep 29 - Oct 03
Form 4
7.08%
587.21K
$8.90
$5.23M
Sep 28, 2022
8.88M
Purchase
Sep 26 - Sep 28
Form 4
9.03%
686.71K
$11.53
$7.92M
Sep 07, 2022
8.29M
Purchase
Sep 02 - Sep 07
Form 4
0.66%
50.00K
$12.20
$610.00K
Sep 01, 2022
7.61M
Purchase
Aug 30
Form 4
0.25%
18.90K
$9.21
$174.07K
Aug 02, 2022
7.56M
Purchase
Jul 29
Form 4
0.99%
74.20K
$9.26
$687.18K
Jul 25, 2022
7.54M
Purchase
Jul 21 - Jul 25
Form 4
2.05%
150.00K
$9.18
$1.38M
Jul 20, 2022
7.46M
Purchase
Jul 18 - Jul 20
Form 4
1.31%
94.57K
$9.88
$934.82K
Jul 14, 2022
7.31M
Purchase
Jul 12 - Jul 14
Form 4
1.24%
88.20K
$9.61
$847.23K
Jul 06, 2022
7.22M
Purchase
Jul 01 - Jul 05
Form 4
0.89%
62.87K
$9.76
$613.51K
Jun 30, 2022
7.13M
Purchase
Jun 28 - Jun 30
Form 4
7.48%
492.02K
$10.37
$5.10M
Jun 24, 2022
7.07M
Purchase
Jun 22 - Jun 24
Form 4
0.09%
5.95K
$9.69
$57.67K
Jun 21, 2022
6.58M
Purchase
Jun 16
Form 4
1.83%
118.05K
$8.57
$1.01M
Jun 14, 2022
6.57M
Purchase
Jun 10 - Jun 14
Form 4
10.03%
588.02K
$9.65
$5.67M
Jun 09, 2022
6.45M
Purchase
Jun 07 - Jun 09
Form 4
3.36%
190.87K
$9.16
$1.75M
Jun 06, 2022
5.87M
Purchase
Jun 02 - Jun 06
Form 3
Jun 06, 2022
5.67M
Showing 21 results

Vistagen Therapeutics, Inc.

Investor
Updated Jul 14, 2022
Form 4
-0.29%
-60.00K
$0.89
-$53.40K
Jul 14, 2022
20.64M
Sale
Jul 12
Form 3
Jul 08, 2022
20.70M
Showing 2 results

ARCA biopharma, Inc.

Investor
Updated Feb 28, 2018
Form 4
-100.00%
-1.54M
$0.55
-$846.91K
Feb 28, 2018
Sale
Feb 26 - Feb 27
Showing 1 results